According to a new report by Polaris Market Research, the global intravenous immunoglobulin (IVIG) market was valued at USD 12.66 billion in 2023 and is projected to reach USD 24.13 billion by 2032, expanding at a CAGR of 7.50% over the forecast period. Growth is underpinned by the rising prevalence of immunodeficiency disorders, advancing plasma collection and fractionation...